Clinical Trial Update: 18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study [EARLY_Phase 1]

View source ↗

Summary

Phase 1 dosimetry and biodistribution study of the PET tracer 18F-FAPIBiotin in malignant neoplasms; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 18F-FAPIBiotin

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Malignant Neoplasm | EARLY_Phase 1 | Status: RECRUITING